Sat, Feb 28, 2015, 1:57 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

CryoLife Inc. Message Board

  • dlhild Mar 9, 2010 7:20 PM Flag

    victorio - this is why they haven't been bought out

    1. Half the company is a low gross profit, highly regulated, high fixed cost business. It would only be attractive to another tissue company.

    2. Bioglue is the other half of the company. Bioglue goes off patent in the US in mid 2012 and the rest of the world in mid 2013. Bioglue is probably a dated product too. In addition, Tenaxis already has a Bioglue knock-off. All they need to do is get their knock-off PMA out of the way. Then in 2012, when Bioglue goes off patent, is to get a US distributor to start selling their knock-off product in the US. If Bioglue sales dropped by $10M-$15M, and if in addition their margins got clipped by 15%-20%, CRY would be at break even. This assumes no major sales from other sources. In 2012, hospitals are going to be ultra cost sensative too. It is even possible they would lose a huge amount of Bioglue sales, resulting in them being an unprofitable company

    3. Biofoam is an unknown at this point.

    CRY's big plus it that they will have $55M cash flow over the next 3 years, assuming they use up the last of the NOL's and tax credits.

    CRY's big negative is their sales pipeline starting in 2013.

    The Tenaxis patent decision blew a major hole in their plans to take over Medafor. No Medafor shareholder in their right mind would want to be acquired by a company with this crappy pipeline. In 2014, as stand alone companies, Medafor may be worth more than CRY.

    No buy-out headed CRY's way for a long time Victorio.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

      Hey, you don't need to write so LONG to tell me you are SHORT!!!!!!!! ONE WORD WOULD DO IT!!!!!! Were you trying to convince yourself??????????



10.48-0.24(-2.24%)Feb 27 4:02 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.